As part of a clinical trial. After receiving laser pointer treatment, patients will be treated with the powerful chemotherapy drug doxorubicin. This drug is considered the least likely to penetrate the blood-brain barrier. The primary lesion was ovarian cancer, and he is currently undergoing treatment for recurrent glioma. This tumor is the most difficult type of brain tumor to treat. Most patients diagnosed with this type of brain tumor survive only 15 months, according to statistics from the American Cancer Society. This clinical trial is still in progress. However, this preliminary result is very promising.
What is interesting is that the blood-brain barrier is a pathway that is not unilaterally affected. By making the blood-brain barrier malfunction. It can get the substance into the brain. But breaking the blood-brain barrier can also cause substances to flow from your brain into your blood circulation. Stay with the peripheral system, including your immune system. He is using drugs combined with laser pointer treatment to "amplify the immune system's attack on cancer." The researchers hope to publish their research results later this year.